DNMT3A and acute myeloid leukemia: The mean age at the time of AML diagnosis was 40 ± 1.9 years, and no significant correlation was detected between age at the time of diagnosis and either CREBBP (p-value = 0.322), CEBPA (p-value = 0.955) or DNMT3A (p-value = 0.233).